Clinical Trial Update: Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer [Phase 3]

View source ↗

Summary

A phase 3 randomized trial evaluating pelvic and aortic-cava lymphadenectomy for ovarian cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Ovarian Cancer | Phase 3 | Status: SUSPENDED